New Research Center Aims to Deliver
Breakthrough Advancements in Dermatology and Discover Solutions for
Healthy and Allergic Skin
Clinique and Icahn School of Medicine at Mount Sinai today
announced a philanthropic partnership to establish the Mount
Sinai-Clinique Healthy Skin Dermatology Center. The Center will
develop forward-thinking research in dermatology, exploring the
biological underpinnings of how skin ages, skin allergies and
inflammatory or eczematous skin conditions, including eczema (or
atopic dermatitis) and contact dermatitis. Rooted in a shared
mission to conduct dermatological research that improves patients’
lives, the partnership will focus on applicable scientific
discovery and leading-edge innovation to modernize allergy science
in order to identify innovative solutions for these skin
conditions.
Research conducted under the Mount Sinai-Clinique Healthy Skin
Dermatology Center aims to uncover scientific findings to
accelerate the creation of new topical and systemic treatments that
help alleviate allergic skin conditions. The priority is to bridge
basic science with practical application in the clinic to improve
people’s lives through healthy skin. By investigating healthy skin,
along with the skin of those with atopic dermatitis and other
allergic skin disorders, the researchers may learn how to
significantly slow the visible signs of aging in all people as well
as in patients with eczema, who show signs of premature or
accelerated aging. Insights from this research aim to spur advances
in the field of dermatology and skin health. Additionally, they
will inform and inspire Clinique in future product innovation to
offer further solutions for people with allergic or sensitive
skin.
“As a brand that has offered dermatologist guided solutions and
allergy tested solutions since its inception, Clinique is proud to
partner with the renowned institution of Icahn Mount Sinai and its
team of physician-scientists, led by a world-renowned expert in
allergic and inflammatory skin diseases, Dr. Emma Guttman. We are
inspired by the team’s dedication to the research and future
discoveries of allergic skin and its life impact, including aging.
We are energized by our mutual commitment and steadfast belief that
great skin can be created and maintained for all. I am confident
that this first-of-its-kind partnership will enable groundbreaking
research by leading physician-scientists dedicated to advancing
allergy science,” Michelle Freyre, President, Global Brands,
Clinique.
Dr. Emma Guttman, MD, PhD, Waldman Professor and System Chair,
Department of Dermatology at the Icahn School of Medicine, a
trailblazer in dermatologic science, has dedicated her career to
bridging science with practice intended to improve patients’ lives.
Her work has led to novel therapeutic targets for patients
suffering from inflammatory skin conditions. Drawing inspiration
from her personal and family history of eczema and other allergic
conditions, Dr. Guttman has made it her mission to alleviate
sensitive skin.
“Years of chronic inflamed skin plays a role in premature aging.
Extensive research has helped us understand the molecular map of
skin conditions associated with allergy such as eczema and contact
dermatitis, and we’re now at a pivotal point in addressing these
conditions and more. With Clinique’s support, we will continue to
actively explore targeted approaches to reversing eczematous and
allergic skin conditions with the goal of creating and sustaining
healthy skin. In turn, we want to use this understanding to address
and prevent the process of age-related inflammation or
‘inflammaging’ in the first place,” says Dr. Guttman, who also
directs the Center of Excellence in Eczema at Mount Sinai and the
Laboratory of Inflammatory Skin Diseases at Icahn Mount Sinai.
The laboratory of Inflammatory Skin Diseases at Icahn Mount
Sinai has a major focus on atopic dermatitis, contact dermatitis,
alopecia areata, and other inflammatory skin diseases. It has made
paradigm-shifting discoveries on the immunologic basis of atopic
dermatitis, opening the door to new therapeutics. Dr. Guttman’s lab
developed the only comprehensive molecular maps of atopic
dermatitis, defining skin differentiation and immune-circuits
characterizing this disease across phenotypes and ages. This work
on atopic dermatitis/eczema has contributed directly to many of the
recently developed treatments for this disease, earning Dr. Guttman
and her lab a unique place as being a top leader in dermatology and
immunology worldwide.
Clinique has a long-standing history of partnering with
dermatologists, including its Founding Dermatologist, Norman
Orentreich, MD, and incorporating patients’ insights in its
innovation since 1968. His children, Catherine Orentreich, MD, and
David Orentreich, MD, the brand’s Guiding Dermatologists, continue
their father’s legacy for Clinique. Dr. David Orentreich is
Assistant Clinical Professor of Dermatology at Icahn Mount Sinai,
and he and Dr. Catherine Orentreich are members of the Mount Sinai
Dermatology Advisory Board.
In this meaningful mission, Clinique has made a philanthropic
commitment of $5 million over seven years for the advancement and
evolution of allergy science through the partnership and founding
of the Mount Sinai-Clinique Healthy Skin Dermatology Center. The
funds will be used to recruit the best and brightest physicians and
scientists, and provide resources for the most advanced equipment,
clinical and laboratory space, and key support staff. The studies
conducted by the Mount Sinai-Clinique Healthy Skin Dermatology
Center will include all ages, genders, races and ethnicities, and
will also investigate the effects of factors such as diet,
exercise, and stress on the skin of healthy people. Mount Sinai
predicts that with Clinique’s support, critical breakthroughs will
be fast-tracked, from the earliest stages of the multiyear
partnership.
About Mount Sinai Health System: Mount Sinai Health System is
one of the largest academic medical systems in the New York metro
area, with more than 43,000 employees working across eight
hospitals, more than 400 outpatient practices, more than 300 labs,
a school of nursing, and a leading school of medicine and graduate
education. Mount Sinai advances health for all people, everywhere,
by taking on the most complex health care challenges of our
time—discovering and applying new scientific learning and
knowledge; developing safer, more effective treatments; educating
the next generation of medical leaders and innovators; and
supporting local communities by delivering high-quality care to all
who need it. Through the integration of its hospitals, labs, and
schools, Mount Sinai offers comprehensive health care solutions
from birth through geriatrics, leveraging innovative approaches
such as artificial intelligence and informatics while keeping
patients’ medical and emotional needs at the center of all
treatment. The Health System includes approximately 7,400 primary
and specialty care physicians; 13 joint-venture outpatient surgery
centers throughout the five boroughs of New York City, Westchester,
Long Island, and Florida; and more than 30 affiliated community
health centers. Hospitals within the System are consistently ranked
by Newsweek’s® “The World’s Best Smart Hospitals, Best in State
Hospitals, World Best Hospitals and Best Specialty Hospitals” and
by U.S. News & World Report's® “Best Hospitals” and “Best
Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News
& World Report® “Best Hospitals” Honor Roll for 2023-2024.
About Clinique: In 1968, a beauty editor asked a leading New
York City dermatologist, “Can great skin be created?” The answer:
yes. And with that yes, Clinique was born. Today Clinique is the #1
Dermatologist Brand in Skincare in the US* and #1 Dermatologist
Brand in Makeup in the US**, offering its dermatologist guided,
allergy tested solutions for remarkable skin results. The brand is
sold in 107 markets worldwide. Clinique’s clinical solutions are
informed by years of research, working with dermatologists,
scientists, and ophthalmologists. All Clinique formulas are
designed to deliver powerful efficacy with rigorous safety
—clinically proven, allergy tested, and 100% fragrance free.
*Source: Circana, U.S. Prestige Beauty Total Measured Market,
Skincare Unit Sales, Derm Brand Attribute, 12 Months Ending
December 2023 **Source: Circana, U.S. Prestige Beauty Total
Measured Market, Makeup Unit Sales, Derm Brand Attribute, 12 Months
Ending December 2023
Derm Brand is defined as a brand that was founded or developed
by a dermatologist and/or is dermatologist recommended.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240202954316/en/
Icahn Mount Sinai: Laura Ruocco-Duran:
Laura.Ruocco-Duran@mountsinai.org Clinique: Dorota Sekulska:
DSekulsk@clinique.com
Estee Lauder Companies (NYSE:EL)
Historical Stock Chart
From Apr 2024 to May 2024
Estee Lauder Companies (NYSE:EL)
Historical Stock Chart
From May 2023 to May 2024